Showing results (11-20 of 140) with videos related to
Sort By:
Pageof 14
Brain Research|July 21, 2007
17Beta-estradiol reduces nitrotyrosine immunoreactivity and increases SOD1 and SOD2 immunoreactivity in nigral neurons in male mice following MPTP insultWanida Tripanichkul, Kittisak Sripanichkulchai, James A Duce, et al.Plos One|April 6, 2013
Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic functionAdam W Oaks, Maya Frankfurt, David I Finkelstein, et al.Neurobiology of Disease|September 15, 2023
Understanding the potential causes of gastrointestinal dysfunctions in multiple system atrophyColin F Craig, David I Finkelstein, Rachel M McQuade, et al.Parkinson'S Disease|July 21, 2021
α-Synuclein E46K Mutation and Involvement of Oxidative Stress in a Drosophila Model of Parkinson's DiseaseSamaneh Reiszadeh Jahromi, S R Ramesh, David I Finkelstein, et al.Frontiers in Aging Neuroscience|July 9, 2014
Role of metal ions in the cognitive decline of Down syndromeNakisa Malakooti, Melanie A Pritchard, Paul A Adlard, et al.Journal of Personalized Medicine|February 25, 2022
Gastrointestinal Dysfunction in Parkinson's Disease: Current and Potential TherapeuticsMyat Noe Han, David I Finkelstein, Rachel M McQuade, et al.Frontiers in Neuroscience|February 21, 2022
Effects of Excess Iron on the Retina: Insights From Clinical Cases and Animal Models of Iron DisordersAli Shahandeh, Bang V Bui, David I Finkelstein, et al.The Journal of Biological Chemistry|May 9, 2019
The role of lipids in α-synuclein misfolding and neurotoxicityCathryn L Ugalde, Victoria A Lawson, David I Finkelstein, et al.Journal of Neuroscience Research|July 10, 2020
Therapeutic applications of chelating drugs in iron metabolic disorders of the brain and retinaAli Shahandeh, Bang V Bui, David I Finkelstein, et al.Signal Transduction and Targeted Therapy|December 22, 2017
Transferrin protects against Parkinsonian neurotoxicity and is deficient in Parkinson's substantia nigraScott Ayton, Peng Lei, Catriona Mclean, et al.Pageof 14